Saturday 17 October 2026 Export SLN’s income statement to Excel — free account

Silence Therapeutics PLC Sponsored ADR

Silence Therapeutics PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $559,000.00, down 98.7% from fiscal 2024. In the quarter to June 2026, revenue grew 197.2%, EPS grew 54.4% and free cash flow grew 107.0%, each against the same quarter a year earlier.

8.68 0.67 −7.17%

Follow SLN

Alert me

Market cap: $581.1M
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: 2/9
Altman Z: −4.82
Beneish M: 45.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	—	3	1	4	+8 more TTM periods Free account
ROE Full definition →	(90.41%)	(236.94%)	(90.27%)	(65.53%)
ROA Full definition →	(44.14%)	(49.96%)	(53.05%)	(35.16%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(72.33%)	(80.01%)	(83.11%)	(54.74%)
Average Days of Receivables Full definition →	0.00	9,664.89	14,369.51	313.42
Free Cash Flow per Share Full definition →	(0.89)	(1.39)	(1.32)	(1.54)
Free Cash Flow Full definition →	(42.26)	(65.56)	(62.33)	(72.58)
Capital Expenditures Full definition →	—	—	(0.05)	(0.12)
Other line items
Cash ROIC Full definition →	(38.24%)	(54.86%)	(42.26%)	(41.18%)
Accounts Receivable Turnover Full definition →	0.00	0.04	0.02	1.18
Accounts Payable Turnover Full definition →	0.00	0.01	0.01	0.13
Inventory Turnover Full definition →	—	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	21,999.74	22,674.14	2,767.71
Days of Inventory on Hand Full definition →	—	0.00	0.00	0.00
Tax Rate Full definition →	0.01	0.00	0.00	0.01
Research and Development Expense of Revenue Full definition →	0.00%	6,682.00%	12,120.39%	313.90%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	2,584.74%	3,997.14%	93.51%
Share Based Compensation of Revenue Full definition →	0.00%	832.06%	1,444.36%	47.00%
Operating CF/Net income Full definition →	0.70	0.87	0.70	1.12
Depreciation/Fixed assets Full definition →	0.36	0.37	0.35	0.35
Capex/Depreciation Full definition →	0.00	0.00	(0.10)	(0.20)
Revenue per Share Full definition →	0.00	0.02	0.01	0.55
Operating CF per Share Full definition →	(0.89)	(1.39)	(1.32)	(1.53)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	—	0.00	0.10	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly